Intuitive Surgical Stock Plummets to 65th in Trading Volume Amid Deutsche Bank Downgrade

On June 10, 2025, Intuitive Surgical (ISRG) saw a 0.66% increase in its stock price, marking the third consecutive day of gains. However, the stock has experienced a 4.93% decline over the past three days. The company's trading volume reached $10.68 billion, a significant drop of 57.19% from the previous day, placing it at the 65th position in terms of trading volume for the day.

Deutsche Bank has downgraded Intuitive Surgical's stock rating from "Hold" to "Sell," citing concerns about near-term risks and potential competition. The bank has set a price target of $440 for the stock, indicating a potential downside of over 16%. This downgrade comes despite the strong performance of Intuitive's da Vinci surgical system, which has been used in over 3 million procedures since its FDA approval in 2000.

Analysts at Deutsche Bank point to the rising popularity of remanufactured surgical tools and new soft-tissue surgical robots developed by rivals such as Medtronic and Johnson & Johnson as potential threats to Intuitive's market dominance. While the da Vinci brand remains strong, any shift toward lower-cost alternatives could impact Intuitive's revenue and profitability.

Currently, only Deutsche Bank and Morningstar Equity Research have "Sell" or "Underweight" ratings on the stock. Despite this, Intuitive Surgical's stock has seen a significant increase of over 25% over the past year and has more than doubled since 2022. The company's long-term prospects remain positive, but investors may need to reassess their positions in light of the recent downgrade and potential competitive pressures.